zx-7101a
Small moleculeexperimental
Clinical trial activity
11 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
3
Phase 3
4
Phase 4
0
Earliest trial started Dec 1, 2021 (NCT05217732)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07095257 | Phase 3 | Oct 13, 2025 | Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
| NCT06841926 | Phase 1 | Feb 20, 2025 | Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
| NCT06669351 | Phase 3 | Nov 30, 2024 | Hangzhou Zenshine Pharmaceuticals Co., Ltd., Zhejiang University |
| NCT06099873 | Phase 3 | Oct 25, 2023 | Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
| NCT06057103 | Phase 1 | Aug 25, 2023 | Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
| NCT05955027 | Phase 1 | Aug 15, 2023 | Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
| NCT05949385 | Phase 1 | Jul 12, 2023 | Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
| NCT05720091 | Phase 1 | Feb 13, 2023 | Hangzhou Zenshine Pharmaceuticals Co., Ltd., Soochow University |
| NCT05711797 | Phase 1 | Nov 2, 2022 | Fudan University, Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
| NCT05702489 | Phase 2/Phase 3 (Phase 3) | Sep 17, 2022 | Fudan University, Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
| NCT05217732 | Phase 1 | Dec 1, 2021 | Hangzhou Zenshine Pharmaceuticals Co., Ltd. |
Showing 11 of 11 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hangzhou Zenshine Pharmaceuticals Co., Ltd. | For profit | 11 | 11 | 2 | 2021 |
| Fudan University | Academic/Hospital | 2 | 0 | 2 | 2022 |
| Soochow University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Zhejiang University | Academic/Hospital | 1 | 0 | 1 | 2024 |
4 organizations
Page 1 / 1